Weight loss with the investigational incretin analog liraglutide targets fat mass preferentially over muscle, Swedish researchers found.
Read More »ADA: New Insulin Sensitizer May Provide Alternative to Glitazones
An investigational insulin-sensitizing drug for type 2 diabetes seemed in a small study to have the efficacy of thiazolidinedione agents with less potential for side effects.
Read More »ADA: Roche Moves GLP-1 Diabetes Drug Into Phase III Trial
Roche’s investigational type 2 diabetes drug taspoglutide has demonstrated significant improvements in glucose control and weight loss after only eight weeks of treatment with a safety and tolerability profile that supports entry into Phase III.
Read More »ADA: HEART2D Study Shows No Cardiovascular Benefit by Targeting Postprandial Glucose Levels
A study examining the effects of hyperglycemia on type 2 diabetes patients after acute myocardial infarction (AMI), the Hyperglycemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients With Type 2 Diabetes (HEART2D) study, found no cardiovascular benefits from tightly controlling postprandial variations in blood glucose. See …
Read More »Treated Diabetes Associated With Increased Risk for Depression
Persons with treated type 2 diabetes are at increased risk for developing depression, while a more modest association was found between persons with depression and the risk of diabetes, according to a new study.
Read More »Hemoglobin A1C Levels Strongly Linked to Subsequent Mortality in Diabetes
Hemoglobin A1C (A1C) levels are strongly associated with subsequent mortality in both men and women without a previous diabetes diagnosis, according to the results of the largest study to date of A1C levels and subsequent mortality risk, reported in the June issue of Diabetes Care. In those without known diabetes at …
Read More »Diabetic Ulcer Gel Gets Black Box Warning
A black box warning has been added to the safety labeling for becaplermin gel (Regranex, Johnson & Johnson) to warn of the increased risk for cancer mortality in patients who use 3 or more tubes of the product, the US Food and Drug Administration (FDA) announced on Friday.
Read More »Screening for Type 2 Diabetes Not Recommended in Most Cases?
Except possibly for hypertensive patients, screening for type 2 diabetes provides few benefits, according to a report in the June 3rd Annals of Internal Medicine. Accordingly, revised guidelines from the U.S. Preventive Services Task Force (USPSTF) recommend screening only for adults with sustained blood pressure above 135/80 mm Hg. See Publishers …
Read More »Further Evidence Supports Vitamin-D-Deficiency Link to CHD
Further evidence that vitamin-D deficiency may increase the risk of heart disease has come from a new case-control study.
Read More »A1c is Changing to Average Mean Blood Glucose
A1C Translation to Estimated Average Glucose (eAG) Units Will Yield Easier Patient Education. New more accurate formula used to convert A1c to average blood glucose.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.